Bodurka D - Search Results

1

Response and survival in patients with progressive or recurrent serous ovarian tumors of low malignant potential.

Crispens MA, Bodurka D, Deavers M, Lu K, Silva EG, Gershenson DM. Crispens MA, et al. Among authors: bodurka d. Obstet Gynecol. 2002 Jan;99(1):3-10. doi: 10.1016/s0029-7844(01)01649-0. Obstet Gynecol. 2002. PMID: 11777502

2

Growth suppression of human ovarian cancer cell lines by the introduction of a p16 gene via a recombinant adenovirus.

Wolf JK, Kim TE, Fightmaster D, Bodurka D, Gershenson DM, Mills G, Wharton JT. Wolf JK, et al. Among authors: bodurka d. Gynecol Oncol. 1999 Apr;73(1):27-34. doi: 10.1006/gyno.1998.5259. Gynecol Oncol. 1999. PMID: 10094876

3

Trends among gynecologic oncology inpatient deaths: is end-of-life care improving?

Dalrymple JL, Levenback C, Wolf JK, Bodurka DC, Garcia M, Gershenson DM. Dalrymple JL, et al. Gynecol Oncol. 2002 May;85(2):356-61. doi: 10.1006/gyno.2002.6616. Gynecol Oncol. 2002. PMID: 11972400

4

Patient preferences regarding side effects of chemotherapy for ovarian cancer: do they change over time?

Sun CC, Bodurka DC, Donato ML, Rubenstein EB, Borden CL, Basen-Engquist K, Munsell MF, Kavanagh JJ, Gershenson DM. Sun CC, et al. Gynecol Oncol. 2002 Oct;87(1):118-28. doi: 10.1006/gyno.2002.6807. Gynecol Oncol. 2002. PMID: 12468352

5

Phase II trial of irinotecan in patients with metastatic epithelial ovarian cancer or peritoneal cancer.

Bodurka DC, Levenback C, Wolf JK, Gano J, Wharton JT, Kavanagh JJ, Gershenson DM. Bodurka DC, et al. J Clin Oncol. 2003 Jan 15;21(2):291-7. doi: 10.1200/JCO.2003.02.091. J Clin Oncol. 2003. PMID: 12525521 Clinical Trial.

6

beta-catenin nuclear localization is associated with grade in ovarian serous carcinoma.

Lee CM, Shvartsman H, Deavers MT, Wang SC, Xia W, Schmandt R, Bodurka DC, Atkinson EN, Malpica A, Gershenson DM, Hung MC, Lu KH. Lee CM, et al. Gynecol Oncol. 2003 Mar;88(3):363-8. doi: 10.1016/s0090-8258(02)00015-x. Gynecol Oncol. 2003. PMID: 12648588

7

Sarcomatoid carcinoma of the cervix.

Brown J, Broaddus R, Koeller M, Burke TW, Gershenson DM, Bodurka DC. Brown J, et al. Gynecol Oncol. 2003 Jul;90(1):23-8. doi: 10.1016/s0090-8258(03)00200-2. Gynecol Oncol. 2003. PMID: 12821337

8

Mentorship and productivity among gynecologic oncology fellows.

Ramondetta LM, Bodurka DC, Tortolero-Luna G, Gordinier M, Wolf JK, Gershenson DM, Sciscione AC. Ramondetta LM, et al. J Cancer Educ. 2003 Spring;18(1):15-9. doi: 10.1207/s15430154jce1801_9. J Cancer Educ. 2003. PMID: 12825629

9

Expression of c-ABL, c-KIT, and platelet-derived growth factor receptor-beta in ovarian serous carcinoma and normal ovarian surface epithelium.

Schmandt RE, Broaddus R, Lu KH, Shvartsman H, Thornton A, Malpica A, Sun C, Bodurka DC, Gershenson DM. Schmandt RE, et al. Cancer. 2003 Aug 15;98(4):758-64. doi: 10.1002/cncr.11561. Cancer. 2003. PMID: 12910520 Free article.

10

Uterine epithelioid leiomyosarcomas with clear cells: reactivity with HMB-45 and the concept of PEComa.

Silva EG, Deavers MT, Bodurka DC, Malpica A. Silva EG, et al. Am J Surg Pathol. 2004 Feb;28(2):244-9. doi: 10.1097/00000478-200402000-00013. Am J Surg Pathol. 2004. PMID: 15043315

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

153 results

Search Page

Filters